Background: Magnetic resonance imaging (MRI) is the modality of choice for evaluation of intracranial lesions, offering superior soft-tissue contrast, multiplanar capability, and a range of advanced sequences (DWI, perfusion, spectroscopy) that augment diagnostic specificity. Histopathology, obtained through stereotactic biopsy or surgical resection, remains the diagnostic gold standard. Real-world correlation between MRI-based pre-operative diagnosis and histopathological confirmation provides a critical metric of imaging accuracy.